👏 We are proud to announce Dr. Xin Zhou, Ph.D., as the recipient of the 𝟮𝟬𝟮𝟱 𝗝𝗮𝗺𝗲𝘀 𝗦. 𝗛𝘂𝘀𝘁𝗼𝗻 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗔𝘄𝗮𝗿𝗱!
Dr. Zhou was selected for her pioneering work in protein engineering and chemical biology, advancing understanding of immune signaling, cancer drug resistance, and therapeutic reprogramming. She will present her research at the upcoming 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗘𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 & 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 in San Diego this December, and we look forward to her talk.
Dr. Zhou is an Assistant Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and of Cancer Biology at Dana-Farber Cancer Institute.
𝗔𝗯𝗼𝘂𝘁 𝗗𝗿. 𝗭𝗵𝗼𝘂 𝗮𝗻𝗱 𝗵𝗲𝗿 𝗹𝗮𝗯:
She holds a Ph.D. in Bioengineering from Stanford University School of Medicine and completed postdoctoral research at University of California, San Francisco as a Merck – Damon Runyon Cancer Research Foundation Fellow. Since joining Dana-Farber and Harvard in 2022, her lab has developed technologies in protein engineering and chemical biology to study cancer and immune signaling, drug resistance, and metastasis, and to engineer self-regulated antibodies, enzymes, and cells for therapeutic reprogramming.
𝗛𝗲𝗿 𝗺𝗮𝗻𝘆 𝗵𝗼𝗻𝗼𝗿𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲:
V Foundation Women Scientists Innovation Award for Cancer Research, NIH Director’s New Innovator Award (DP2), Damon Runyon Dale F. Frey Award for Breakthrough Scientists, Helen Gurley Brown Foundation Trailblazer Award, Dana-Farber Innovations Therapeutic Accelerator LEAP Award, MIT Technology Review Innovators Under 35 (China region), PEGS Protein & Antibody Engineering Summit Young Scientist Keynote Award, and the NIH K99/R00 Pathway to Independence Award.
𝗠𝗮𝗻𝘆 𝗰𝗼𝗻𝗴𝗿𝗮𝘁𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗗𝗿. 𝗭𝗵𝗼𝘂 𝗼𝗻 𝘁𝗵𝗶𝘀 𝘄𝗲𝗹𝗹 𝗱𝗲𝘀𝗲𝗿𝘃𝗲𝗱 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻! 🏆
If you are an early-career scientist interested in participating in next year’s award, you can learn more about the submission guidelines.
